Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium
Latest Publications

TOTAL DOCUMENTS

24

(FIVE YEARS 0)

H-INDEX

1

(FIVE YEARS 0)

Published By Springer Netherlands

9781402058882

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

State-of-the-art therapy in accordance with guidelines

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_9 ◽

2007 ◽

pp. 73-84

Author(s):

S. P. L. Travis

Keyword(s):

Art Therapy ◽

State Of The Art

Download Full-text

Classification of inflammatory bowel disease can only be based on the clinical phenotype

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_5 ◽

2007 ◽

pp. 39-47

Author(s):

W. Reinisch

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Clinical Phenotype ◽

Inflammatory Bowel

Download Full-text

T-cell modulating antibodies in inflammatory bowel disease

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_24 ◽

2007 ◽

pp. 194-201

Author(s):

D. C. Baumgart

Keyword(s):

Inflammatory Bowel Disease ◽

T Cell ◽

Bowel Disease ◽

Inflammatory Bowel

Download Full-text

Immunosuppression with tacrolimus, everolimus and sirolimus

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_23 ◽

2007 ◽

pp. 190-193

Author(s):

K. Fellermann

Download Full-text

Retarded release phosphatidylcholine: a new therapeutic option for ulcerative colitis

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_19 ◽

2007 ◽

pp. 161-170 ◽

Author(s):

M. Karner ◽

R. Ehehalt ◽

W. Stremmel

Keyword(s):

Ulcerative Colitis ◽

Therapeutic Option

Download Full-text

Oligonucleotides — new therapeutic approaches

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_16 ◽

2007 ◽

pp. 139-145

Author(s):

D. Rachmilewitz ◽

E. Raz

Keyword(s):

Therapeutic Approaches ◽

New Therapeutic Approaches

Download Full-text

State-of-the-Art Lecture: Distinct antibacterial-defensin deficiencies in small intestinal and colonic Crohn’s disease

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_15 ◽

2007 ◽

pp. 128-136

Author(s):

J. Wehkamp ◽

E. -F. Stange

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

State Of The Art ◽

Small Intestinal

Download Full-text

Can immunomodulatory therapy be improved by metabolite measurement and combination therapy?

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_11 ◽

2007 ◽

pp. 99-106

Author(s):

W. J. Sandborn

Keyword(s):

Combination Therapy ◽

Immunomodulatory Therapy ◽

Metabolite Measurement

Download Full-text

Increased risk of morbidity associated with immunomodulatory treatment in patients with inflammatory bowel diseases

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_10 ◽

2007 ◽

pp. 85-98

Author(s):

J. -F. Colombel ◽

M. Toruner

Keyword(s):

Inflammatory Bowel Diseases ◽

Immunomodulatory Treatment ◽

Increased Risk ◽

Bowel Diseases ◽

Inflammatory Bowel

Download Full-text

Helminth ova therapy for inflammatory bowel disease

Immunoregulation in Inflammatory Bowel Diseases — Current Understanding and Innovation - Falk Symposium ◽

10.1007/978-1-4020-5889-9_18 ◽

2007 ◽

pp. 154-160

Author(s):

R. W. Summers ◽

D. E. Elliott ◽

J. V. Weinstock

Keyword(s):

Inflammatory Bowel Disease ◽

Bowel Disease ◽

Inflammatory Bowel

Download Full-text